Individuals Stopping Anti-Obesity Injections Put On Pounds at a Quadrupled Rate Compared to Dieters

Image of pharmaceutical injection and weighing machine
Weight management often requires ongoing approaches.

A recent study suggests that individuals who stop using blockbuster slimming jabs like Mounjaro or Wegovy can put back on reduced body mass at a significantly accelerated pace than those who stop conventional diet and exercise plans.

Findings released in a prominent health publication demonstrates that while obese people frequently drop substantial amounts of their body weight while using the jabs, the mass is regained at an estimated rate of nearly a kilo each month once they quit.

"Individuals purchasing such drugs should be informed of the risk of rapid weight regain when the medication is stopped," stated researcher Dr. Susan Jebb.

This pace of regain means a reversion to original mass in about 18 months.

Weighing Treatments

The research, which reviewed 37 of trials involving thousands of participants, compared the effects of these new drugs with older methods.

Researchers note that individuals who lose weight through diet and exercise usually experience a more gradual creep back—approximately 0.1 kg a month—post-intervention.

Explaining the Fast Rebound

Experts propose the mode of action of the drugs accounts for the amplified rebound.

GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which controls appetite.

"Sustained high doses of the hormone levels several times higher than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this hormone supplement results in hunger is unsuppressed, making overeating much more probable."

An Ongoing Condition?

The NHS advise the injections for people with obesity-related medical conditions, alongside prescribed diet and exercise modifications.

Professionals contend that, due to the likelihood of weight regain, the therapy is often life-long.

This perspective is echoed by drug manufacturers, who note that the findings "underscore the long-term nature of excess weight," comparing it to managing conditions like diabetes.

User Testimonies

Individuals who have stopped the jabs report a sudden return of appetite.

"It felt as if a switch that goes on and you become ravenous," said an individual.

The struggle is exacerbated if users have not adopted permanent lifestyle or habit changes during treatment.

Growing Adoption

Figures indicate that a significant number of adults in the UK have tried these injections in the past year, with desire being substantial.

  • Adoption is more common among females than men.
  • The 40s and 50s demographic shows the highest level of interest.
  • Many obtain the drugs through private healthcare rather than the NHS.

In conclusion, clinicians caution that while the jabs are powerful agents for weight loss, they are not a magic solution and long-term success likely depends on integrated lifestyle management.

Dustin Powell
Dustin Powell

A seasoned slot gaming analyst with over a decade of experience in casino entertainment and strategy development.